Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet K Coller

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 20, 2006
CYP2B6, CYP2D6, and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomesBenjamin J Davies, Janet K Coller, Andrew A Somogyi, et al.
British Journal of Clinical Pharmacology|March 5, 2004
CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomesMark R Hutchinson, Andrew Menelaou, David J R Foster, et al.
International Journal of Cancer|August 30, 2018
The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicityKate R Secombe, Janet K Coller, Rachel J Gibson, et al.
In Silico Pharmacology|November 28, 2022
Structural insight and analysis of TLR4 interactions with IAXO-102, TAK-242 and SN-38: an in silico approachJanine S Y Tam, Jinxin V Pei, Janet K Coller, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|March 5, 2021
Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammationJanine S Y Tam, Janet K Coller, Patrick A Hughes, et al.
British Journal of Clinical Pharmacology|January 29, 2019
Relationship between allograft cyclosporin concentrations and P-glycoprotein expression in the 1st month following renal transplantationBenedetta C Sallustio, Benjamin D Noll, Janet K Coller, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 20, 2015
Chemotherapy-induced gut toxicity and pain: involvement of TLRsRachel J Gibson, Janet K Coller, Hannah R Wardill, et al.
British Journal of Clinical Pharmacology|September 19, 2007
Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineBenjamin J Davies, Megan K Herbert, Janet K Coller, et al.
Pain|September 21, 2016
Ethnicity-dependent influence of innate immune genetic markers on morphine PCA requirements and adverse effects in postoperative painAndrew A Somogyi, Alex T Sia, Ene-Choo Tan, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 14, 2006
Determination of the 4-monohydroxy metabolites of perhexiline in human plasma, urine and liver microsomes by liquid chromatographyBenjamin J Davies, Megan K Herbert, Janet K Coller, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 20, 2006
CYP2B6, CYP2D6, and CYP3A4 catalyze the primary oxidative metabolism of perhexiline enantiomers by human liver microsomesBenjamin J Davies, Janet K Coller, Andrew A Somogyi, et al.
British Journal of Clinical Pharmacology|March 5, 2004
CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomesMark R Hutchinson, Andrew Menelaou, David J R Foster, et al.
International Journal of Cancer|August 30, 2018
The bidirectional interaction of the gut microbiome and the innate immune system: Implications for chemotherapy-induced gastrointestinal toxicityKate R Secombe, Janet K Coller, Rachel J Gibson, et al.
In Silico Pharmacology|November 28, 2022
Structural insight and analysis of TLR4 interactions with IAXO-102, TAK-242 and SN-38: an in silico approachJanine S Y Tam, Jinxin V Pei, Janet K Coller, et al.
Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology|March 5, 2021
Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammationJanine S Y Tam, Janet K Coller, Patrick A Hughes, et al.
British Journal of Clinical Pharmacology|January 29, 2019
Relationship between allograft cyclosporin concentrations and P-glycoprotein expression in the 1st month following renal transplantationBenedetta C Sallustio, Benjamin D Noll, Janet K Coller, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 20, 2015
Chemotherapy-induced gut toxicity and pain: involvement of TLRsRachel J Gibson, Janet K Coller, Hannah R Wardill, et al.
British Journal of Clinical Pharmacology|September 19, 2007
Steady-state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac-perhexilineBenjamin J Davies, Megan K Herbert, Janet K Coller, et al.
Pain|September 21, 2016
Ethnicity-dependent influence of innate immune genetic markers on morphine PCA requirements and adverse effects in postoperative painAndrew A Somogyi, Alex T Sia, Ene-Choo Tan, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|July 14, 2006
Determination of the 4-monohydroxy metabolites of perhexiline in human plasma, urine and liver microsomes by liquid chromatographyBenjamin J Davies, Megan K Herbert, Janet K Coller, et al.
Pageof 7